Stéphane Mathis
Impact in
- Neurology top 1%
- Peripheral Neuropathies and Disorders
- Amyotrophic Lateral Sclerosis Research
- Myasthenia Gravis and Thymoma
- Autoimmune Neurological Disorders and Treatments
-
- Hereditary Neurological Disorders
Papers in
- Neurology 73
- Peripheral Neuropathies and Disorders 53
- Neurology and Historical Studies 11
- Amyotrophic Lateral Sclerosis Research 10
- Myasthenia Gravis and Thymoma 4
-
- Hereditary Neurological Disorders 28
- Co-authors
- Jean‐Michel Vallat (59 shared papers)Laurent Magy (41 shared papers)Gwendal Le Masson (38 shared papers)Jean‐Philippe Neau (28 shared papers)Cyril Goizet (9 shared papers)Antoine Soulages (16 shared papers)Mériem Tazir (10 shared papers)Laurence Richard (22 shared papers)
In The Last Decade
Stéphane Mathis
134 papers receiving 2.4k citations
Stéphane Mathis's Hit Papers
Peers
Comparison fields: 5 of 90
- Neurology 1.2k
- Cellular and Molecular Neuroscience 434
- Clinical Biochemistry 43
- Neurology 69
- Genetics 72
Countries citing papers authored by Stéphane Mathis
This map shows the geographic impact of Stéphane Mathis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stéphane Mathis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stéphane Mathis more than expected).
Fields of papers citing papers by Stéphane Mathis
This network shows the impact of papers produced by Stéphane Mathis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stéphane Mathis. The network helps show where Stéphane Mathis may publish in the future.
Co-authors
The 25 scholars most cited alongside Stéphane Mathis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 136 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 205 | |
| 2 | Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study Hit paper breakdown → | 2023 | 188 |
| 3 | 2016 | 88 | |
| 4 | 2016 | 83 | |
| 5 | 2011 | 81 | |
| 6 | 2015 | 81 | |
| 7 | 2014 | 70 | |
| 8 | 2015 | 63 | |
| 9 | 2012 | 62 | |
| 10 | 2014 | 61 | |
| 11 | 2010 | 60 | |
| 12 | 2011 | 59 | |
| 13 | 2018 | 56 | |
| 14 | 2021 | 48 | |
| 15 | 2013 | 47 | |
| 16 | 2010 | 42 | |
| 17 | 2018 | 41 | |
| 18 | 2020 | 41 | |
| 19 | 2015 | 38 | |
| 20 | 2016 | 35 |
About Stéphane Mathis
Stéphane Mathis is a scholar working on Neurology, Cellular and Molecular Neuroscience, Neurology, Pulmonary and Respiratory Medicine and Clinical Biochemistry, having authored 136 papers that have together received 2.5k indexed citations. Recurring topics across this work include Peripheral Neuropathies and Disorders (53 papers), Hereditary Neurological Disorders (28 papers), Neurology and Historical Studies (11 papers), Amyotrophic Lateral Sclerosis Research (10 papers), Muscle Physiology and Disorders (6 papers), Myasthenia Gravis and Thymoma (4 papers), Vasculitis and related conditions (3 papers) and Metabolism and Genetic Disorders (3 papers). The work is most often cited by research in Neurology (1.2k citations), Cellular and Molecular Neuroscience (434 citations), Clinical Biochemistry (43 citations), Neurology (69 citations) and Genetics (72 citations). Stéphane Mathis has collaborated with scholars based in France, Algeria and Italy. Frequent co-authors include Jean‐Michel Vallat, Laurent Magy, Gwendal Le Masson, Jean‐Philippe Neau, Cyril Goizet, Antoine Soulages, Mériem Tazir, Laurence Richard, Jonathan Ciron and Philippe Corcia. Their work appears in journals such as Journal of Neurology, Journal of the Neurological Sciences, Neurology, Medicine and Neuromuscular Disorders.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.